Flu vaccines didn't work that well in the US, officials find

NEW YORK — As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well, with one of its worst effectiveness rates in more than a decade. A new strain that dominated ...
Fast Company

Europe just approved a combined flu and COVID shot. Why hasn’t the US?

On Friday, Moderna’s mCombriax—a combined vaccine for both the flu and COVID—was recommended for authorization by European regulators, which opens the door for the vaccine’s approval in the European ...
NPR

Despite U.S. pull out from WHO, reps were (virtually) at the table for big flu confab

For the past week, about 50 flu scientists from around the world were crammed into a conference room at a Hilton hotel in Istanbul, Turkey. Their goal was to design a flu shot that will confer the ...
Scientific American

Desert dino find, flu shot U‑turn, universal vaxx hope, air toxin warning

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. You’re listening to our weekly science news roundup. Let’s start off with a vaccine 180.
The Washington Post

Inside RFK Jr.’s push against the flu vaccine that he links to his voice condition

Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...
Wall Street Journal

The Moderna Flu-Shot Drama

The Food and Drug Administration agreed Wednesday to review Moderna’s application to make a new seasonal flu shot available, after initially refusing to do so. The back-and-forth reveals increased ...
The Conversation

FDA’s abrupt flip‑flop on Moderna’s mRNA flu shot highlights growing risks to drug‑makers of investing in vaccines

Ana Santos Rutschman does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...
WOSU Public Media

FDA reverses course on Moderna flu shot

The Food and Drug Administration rattled the biotech industry last week when it said it wouldn't even look at Moderna's application to market the first mRNA flu shot. But on Wednesday, the agency ...
Boston Herald

Moderna says the FDA will consider its new flu shot after resolving a public dispute

WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of ...
Wall Street Journal

FDA Reverses Course and Will Now Review Moderna’s Flu Shot

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA3.60%increase; green up pointing triangle application to sell a new seasonal flu shot after the vaccine ...
PBS

Moderna says FDA will now consider its new mRNA flu shot after initial refusal

WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of ...